Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Impaired insulin secretion is a hallmark of type 2 diabetes (T2D). Epigenetics may affect disease susceptibility. To describe the human methylome in pancreatic islets and determine the epigenetic basis of T2D, we analyzed DNA methylation of 479,927 CpG sites and the transcriptome in pancreatic islets from T2D and non-diabetic donors. We provide a detailed map of the global DNA methylation pattern in human islets, β- and α-cells. Genomic regions close to the transcription start site showed low degrees of methylation and regions further away from the transcription start site such as the gene body, 3'UTR and intergenic regions showed a higher degree of methylation. While CpG islands were hypomethylated, the surrounding 2 kb shores showed an intermediate degree of methylation, whereas regions further away (shelves and open sea) were hypermethylated in human islets, β- and α-cells. We identified 1,649 CpG sites and 853 genes, including TCF7L2, FTO and KCNQ1, with differential DNA methylation in T2D islets after correction for multiple testing. The majority of the differentially methylated CpG sites had an intermediate degree of methylation and were underrepresented in CpG islands (∼ 7%) and overrepresented in the open sea (∼ 60%). 102 of the differentially methylated genes, including CDKN1A, PDE7B, SEPT9 and EXOC3L2, were differentially expressed in T2D islets. Methylation of CDKN1A and PDE7B promoters in vitro suppressed their transcriptional activity. Functional analyses demonstrated that identified candidate genes affect pancreatic β- and α-cells as Exoc3l silencing reduced exocytosis and overexpression of Cdkn1a, Pde7b and Sept9 perturbed insulin and glucagon secretion in clonal β- and α-cells, respectively. Together, our data can serve as a reference methylome in human islets. We provide new target genes with altered DNA methylation and expression in human T2D islets that contribute to perturbed insulin and glucagon secretion. These results highlight the importance of epigenetics in the pathogenesis of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The human methylome in pancreatic islets from 15 T2D and 34 non-diabetic donors. (A) All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. TSS: proximal promoter, defined as 200 bp or 1500 bp upstream of the transcription start site. UTR: untranslated region. CpG island: 200 bp (or more) stretch of DNA with a C+G content of >50% and an observed CpG/expected CpG in excess of 0.6. Shore: the flanking region of CpG islands, 0–2000 bp. Shelf: regions flanking island shores, i.e., covering 2000–4000 bp distant from the CpG island [68]. Global DNA methylation in human pancreatic islets of T2D and non-diabetic donors is shown for (B) each gene region and (C) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. (D) The absolute difference in DNA methylation of 3,116 individual sites, including 2,988 sites with decreased and 128 sites with increased DNA methylation in T2D compared with non-diabetic human islets with q<0.05 based on a FDR analysis. 1,649 sites with an absolute difference in DNA methylation ≥5% are represented by grey bars. (E) Pie chart describing the number of sites that exhibit increased or decreased DNA methylation in T2D compared with non-diabetic human islets with an absolute difference in methylation ≥5% and q<0.05. The degree of DNA methylation is shown for (F) the 1,596 CpG sites with decreased DNA methylation and (G) the 53 sites with increased DNA methylation in T2D vs. non-diabetic islets in comparison to the degree of methylation of all analyzed CpG sites in the human islets using the Infinium HumanMethylation450 BeadChip.](https://figures.cochat.ai/paper-figures/fd8c276c0dc0486e83f24fd1674f0479/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-1.jpg)



![Figure 5 The human methylome in FACS sorted human β- and α-cell fractions. All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. Global DNA methylation in whole human islets (n = 4) and purified human β- (n = 3) and α-cell (n = 2) fractions is shown for (A) each gene region and (B) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. Data are mean ± SEM.](https://figures.cochat.ai/paper-figures/4b940823eaa34b94a0a86ee0b9008d18/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies of pancreatic islets from nondiabetic donors ( 19 , 20 ) and patients with T2D ( 21 ) have identified epigenetic modifications in genes that potentially affect β-cell function.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 2×
“We next exported the DNA methylation data from GenomeStudio and used Bioconductor [82] and the lumi package [83] for further analyses.”
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 2×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“Next a quantile normalization was performed as described [85].”
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 2×
“methylation paradox which still remains unexplained [46].”
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673 · cited 1×
“It has previously been established that DNA methylation in differentiated mammalian cells mainly occurs on cytosines in CG dinucleotides [24].”
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“While some researchers have found a decreased b-cell number and increased a-cell number in human T2D compared with nondiabetic islets, others have not found any differences [69–71].”
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227 · cited 1×
“physical inactivity, the number of patients with T2D has dramatically increased worldwide [1].”
Weber, M., Hellmann, I., Stadler, M. B., Ramos, L., Pääbo, S., Rebhan, M., & Schübeler, D. (2007) · Nature Genetics · doi:10.1038/ng1990 · Cited by 2,221 · cited 1×
“These are known to influence the chromatin structure and DNA accessibility and can thereby regulate gene expression [8,9].”
Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177
Du, P., Zhang, X., Huang, C.-C., Jafari, N., Kibbe, W. A., Hou, L., & Lin, S. M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-587 · Cited by 2,136 · cited 2×
“Because Mvalues are more statistically valid [84], b-values were converted to M-values using the following equation: M = log2 b-value/(12bvalue).”
lumi: a pipeline for processing Illumina microarray
Du, P., Kibbe, W. A., & Lin, S. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn224 · Cited by 2,019 · cited 1×
“Wenextexported the DNA methylation data from GenomeS-tudio and used Bioconductor [82] and the lumi package [83] for further analyses.”
Conserved role of intragenic DNA methylation in regulating alternative promoters
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D’Souza, C., Fouse, S. D., Johnson, B. E., Hong, C., Nielsen, C., Zhao, Y., et al. (2010) · Nature · doi:10.1038/nature09165 · Cited by 1,743
High density DNA methylation array with single CpG site resolution
Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J. M., Delano, D., Zhang, L., Schroth, G. P., Gunderson, K. L., et al. (2011) · Genomics · doi:10.1016/j.ygeno.2011.07.007 · Cited by 1,727 · cited 5×
“Moreover, the array used in our study analyzes DNA methylation genome-wide of ,480,000 CpG sites, covering most gene regions including promoters, 59UTR, gene body and 39UTR in ,99% of RefSeq genes, as well as intergenic regions [68].”
InfluentialChen, Y.-A., Lemire, M., Choufani, S., Butcher, D. T., Grafodatskaya, D., Zanke, B. W., Gallinger, S., Hudson, T. J., & Weksberg, R. (2013) · Epigenetics · doi:10.4161/epi.23470 · Cited by 1,552 · cited 7×
“mapped with a perfect match to the correct genomic location annotated by Illumina [25] and methylation data of those probes”
InfluentialChronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring
Ng, S.-F., Lin, R. C. Y., Laybutt, D. R., Barres, R., Owens, J. A., & Morris, M. J. (2010) · Nature · doi:10.1038/nature09491 · Cited by 1,327
Epigenome-wide association studies for common human diseases
Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3000 · Cited by 1,267 · cited 1×
“Nevertheless, we cannot rule out that some of the identified epigenetic differences are secondary to disease or epiphenomenon [77].”
Doi, A., Park, I.-H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.471 · Cited by 1,177 · cited 2×
“Previous cancer studies suggest that differential DNA methylation mainly occurs in CpG island shores rather than in CpG islands and promoter regions [21,22].”
CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing
Shukla, S., Kavak, E., Gregory, M., Imashimizu, M., Shutinoski, B., Kashlev, M., Oberdoerffer, P., Sandberg, R., & Oberdoerffer, S. (2011) · Nature · doi:10.1038/nature10442 · Cited by 973 · cited 1×
“Moreover, DNA methylation may also regulate alternative splicing events [58] and/or transcription elongation efficiency via alternative promoters [59] when methylation takes place within gene bodies [27].”
Genomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938 · cited 4×
“However, the identified SNPs only explain a small proportion of the estimated heritability of T2D, suggesting that additional genetic factors remain to be identified [3].”
InfluentialHohmeier, H. E., Mulder, H., Chen, G., Henkel-Rieger, R., Prentki, M., & Newgard, C. B. (2000) · Diabetes · doi:10.2337/diabetes.49.3.424 · Cited by 917
Park, J. H., Stoffers, D. A., Nicholls, R. D., & Simmons, R. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33655 · Cited by 640 · cited 2×
“Animal studies further support the hypothesis that epigenetic modifications in pancreatic islets may lead to altered gene expression, impaired insulin secretion and subsequently diabetes [15–17].”
Epigenetics: a molecular link between environmental factors and type 2 diabetes
Ling, C., & Groop, L. (2009) · Diabetes · doi:10.2337/db09-1003 · Cited by 617 · cited 2×
“Epigenetic alterations may subsequently influence phenotype transmission and the development of different diseases, including T2D [7,10].”
Self-citationInsulin resistance and cancer risk: An overview of the pathogenetic mechanisms
Arcidiacono, B., Iiritano, S., Nocera, A., Possidente, K., Nevolo, M. T., Ventura, V., Foti, D., Chiefari, E., & Brunetti, A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/789174 · Cited by 606 · cited 1×
“and cancer [51] as well as studies demonstrating central functions”
On the presence and role of human gene-body DNA methylation
Jjingo, D., Conley, A. B., Yi, S. V., Lunyak, V. V., & Jordan, I. K. (2012) · Oncotarget · doi:10.18632/oncotarget.497 · Cited by 511 · cited 1×
“Interestingly, a recent study suggests a model by which the relationship between gene body DNA methylation and expression is bell shaped and varies depending on the transcriptional activity of the gene, meaning that high levels of gene body methylation are observed in genes with moderate expression levels while low le…”
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion
Ling, C., Del Guerra, S., Lupi, R., Rönn, T., Granhall, C., Luthman, H., Masiello, P., Marchetti, P., Groop, L., & Del Prato, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0916-5 · Cited by 495 · cited 1×
“For PPARGC1A we were unable to compare the methylation data between the two studies as our previous study was based on the average degree of methylation of multiple CpG sites in an analyzed genomic region [11].”
Self-citationVolkmar, M., Dedeurwaerder, S., Cunha, D. A., Ndlovu, M. N., Defrance, M., Deplus, R., Calonne, E., Volkmar, U., Igoillo‐Esteve, M., Naamane, N., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.503 · Cited by 420 · cited 14×
“We found no differences in b -cell content in T2D versus non-diabetic islets, nor did Volkmar et al [14], suggesting that the differences seen in DNA methylation are not due to altered b -cell composition in islets from T2D patients.”
InfluentialIslet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Ahrén, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2782 · Cited by 419
Nitert, M. D., Dayeh, T., Volkov, P., Elgzyri, T., Hall, E., Nilsson, E., Yang, B. T., Lang, S., Parikh, H., Wessman, Y., et al. (2012) · Diabetes · doi:10.2337/db11-1653 · Cited by 403 · cited 1×
“Epigenetic alterations may subsequently influence phenotype transmission and the development of different diseases, including T2D [7,10].”
Self-citationEpigenomic plasticity enables human pancreatic α to β cell reprogramming
Bramswig, N. C., Everett, L. J., Schug, J., Dorrell, C., Liu, C., Luo, Y., Streeter, P. R., Naji, A., Grompe, M., & Kaestner, K. H. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66514 · Cited by 401
Quantitative Trait Loci Analysis Using the False Discovery Rate
Benjamini, Y., & Yekutieli, D. (2005) · Genetics · doi:10.1534/genetics.104.036699 · Cited by 401
DNA Methylation and Demethylation in Mammals
Chen, Z.-X., & Riggs, A. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.205286 · Cited by 395 · cited 3×
“To identify factors that may contribute to differential DNA methylation in human pancreatic islets, we further tested if risk factors for T2D affect islet expression of a number of enzymes which are known to regulate DNA methylation and demethylation in mammals [50].”
InfluentialRakyan, V. K., Down, T. A., Thorne, N. P., Flicek, P., Kulesha, E., Gräf, S., Tomazou, E. M., Bäckdahl, L., Johnson, N., Herberth, M., et al. (2008) · Genome Research · doi:10.1101/gr.077479.108 · Cited by 378 · cited 1×
“The Infinium HumanMethylation450 BeadChip covers 16,232 previously known differentially methylated regions (DMRs) that were selected based on the previously described criteria [21,23].”
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369 · cited 2×
“Since both decreased insulin and increased glucagon secretion from pancreatic islets are known to contribute to hyperglycemia in patients with T2D [49], we investigated whether the identified candidate genes also affect glucagon secretion in clonal a-cells.”
Toperoff, G., Aran, D., Kark, J. D., Rosenberg, M., Dubnikov, T., Nissan, B., Wainstein, J., Friedlander, Y., Levy-Lahad, E., Glaser, B., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr472 · Cited by 349 · cited 1×
“However, recent studies have shown that modest differences in DNA methylation of individual CpG sites can have big effects on gene expression and that in late onset diseases such as T2D small changes in gene expression may have a big effect on disease over long periods of time [64].”
Rakyan, V. K., Beyan, H., Down, T. A., Hawa, M. I., Maslau, S., Aden, D., Daunay, A., Busato, F., Mein, C. A., Manfras, B., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002300 · Cited by 342 · cited 1×
“…in DNA methylation that are found when comparing cancer and normal cells and which is probably due to the presence of an abnormal clone of cells, most of the absolute differences in DNA methylation that have been reported in non-cancer studies are modest in magnitude ranging from 0.13–11% [64–66].”
InfluentialSandovici, I., Smith, N. H., Nitert, M. D., Ackers-Johnson, M., Uribe-Lewis, S., Ito, Y., Jones, R. H., Marquez, V. E., Cairns, W., Tadayyon, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019007108 · Cited by 326
Self-citationOverexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes
Rosengren, A. H., Jokubka, R., Tojjar, D., Granhall, C., Hansson, O., Li, D.-Q., Nagaraj, V., Reinbothe, T. M., Tuncel, J., Eliasson, L., et al. (2010) · Science · doi:10.1126/science.1176827 · Cited by 303 · cited 1×
“Furthermore, glucose-stimulated insulin secretion from human pancreatic islets was measured as described [80].”
Self-citationYang, B. T., Dayeh, T. A., Volkov, P. A., Kirkpatrick, C. L., Malmgren, S., Jing, X., Renström, E., Wollheim, C. B., Nitert, M. D., & Ling, C. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1004 · Cited by 301 · cited 7×
“Madison, USA) as a control for transfection efficiency and luciferase activity was measured as previously described [12].”
InfluentialSelf-citationGenetics of Type 1 Diabetes: What's Next?
Pociot, F., Akolkar, B., Concannon, P., Erlich, H. A., Julier, C., Morahan, G., Nierras, C. R., Todd, J. A., Rich, S. S., & Nerup, J. (2010) · Diabetes · doi:10.2337/db10-0076 · Cited by 300
Pancreatic signals controlling food intake; insulin, glucagon and amylin
Woods, S. C., Lutz, T. A., Geary, N., & Langhans, W. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1858 · Cited by 277 · cited 1×
“Importantly, most of the other islet cell types such as glucagonproducing a-cells, somatostatin-producing d-cells and pancreatic polypeptide producing PP-cells also have key effects on whole body glucose homeostasis [76].”
De Marinis, Y. Z., Salehi, A., Ward, C. E., Zhang, Q., Abdulkader, F., Bengtsson, M., Braha, O., Braun, M., Ramracheya, R., Amisten, S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.007 · Cited by 257
Self-citationYang, B. T., Dayeh, T. A., Kirkpatrick, C. L., Taneera, J., Kumar, R., Groop, L., Wollheim, C. B., Nitert, M. D., & Ling, C. (2011) · Diabetologia · doi:10.1007/s00125-010-1967-6 · Cited by 251 · cited 6×
“Indeed, there are only a few studies to date that have used isolated human b -cells with a maximum number of 16 donors [12,13,73– 75].”
InfluentialSelf-citationFunctional Analysis of Promoter CPG-Methylation using a CpG-Free Luciferase Reporter Vector
Klug, M., & Rehli, M. (2006) · Epigenetics · doi:10.4161/epi.1.3.3327 · Cited by 248 · cited 1×
“Luciferase assays 1500 bp of the human CDKN1A or PDE7B promoters (sequences are given in Table S12) were inserted into a CpG-free firefly luciferase reporter vector (pCpGL-basic) kindly provided by Dr Klug and Dr Rehli [86].”
Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes
Rosengren, A. H., Braun, M., Mahdi, T., Andersson, S. A., Travers, M. E., Shigeto, M., Zhang, E., Almgren, P., Ladenvall, C., Axelsson, A. S., et al. (2012) · Diabetes · doi:10.2337/db11-1516 · Cited by 237
Self-citationProliferation of sorted human and rat beta cells
Parnaud, G., Bosco, D., Berney, T., Pattou, F., Kerr-Conte, J., Donath, M. Y., Bruun, C., Mandrup-Poulsen, T., Billestrup, N., & Halban, P. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0855-1 · Cited by 232 · cited 3×
“Labelling and FACS sorting of the b- and a-cell fractions was performed as previously described [73].”
InfluentialPlasma membrane repair and cellular damage control: The annexin survival kit
Draeger, A., Monastyrskaya, K., & Babiychuk, E. B. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.027 · Cited by 220 · cited 1×
“Finally, based on literature search, genes with known functions in pancreatic islets and/or b -cells [28–40] (Figure 2E), the exocytotic process [41–44] (Figure 2F) and apoptosis [45] (Figure 2G) were found among the genes that showed differential DNA methylation in T2D islets.”
Regulation of calcium in pancreatic α- and β-cells in health and disease
Rorsman, P., Braun, M., & Zhang, Q. (2012) · Cell Calcium · doi:10.1016/j.ceca.2011.11.006 · Cited by 220
Transcriptomes of the major human pancreatic cell types
Dorrell, C., Schug, J., Lin, C. F., Canaday, P. S., Fox, A. J., Smirnova, O., Bonnah, R., Streeter, P. R., Stoeckert, C. J., Kaestner, K. H., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2283-5 · Cited by 216 · cited 1×
“We also tested if any of the genes in Table 2 exhibit differential expression in human b - compared with a -cell fractions using published data by Dorrell et al [26].”
Ammendrup, A., Maillard, A., Nielsen, K., Aabenhus Andersen, N., Serup, P., Dragsbaek Madsen, O., Mandrup-Poulsen, T., & Bonny, C. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1468 · Cited by 212 · cited 2×
“the exocytosis process and apoptosis [28–45].”
Ribel-Madsen, R., Fraga, M. F., Jacobsen, S., Bork-Jensen, J., Lara, E., Calvanese, V., Fernandez, A. F., Friedrichsen, M., Vind, B. F., Højlund, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051302 · Cited by 202 · cited 1×
“13–11% [64–66].”
Dayeh, T. A., Olsson, A. H., Volkov, P., Almgren, P., Rönn, T., & Ling, C. (2013) · Diabetologia · doi:10.1007/s00125-012-2815-7 · Cited by 199 · cited 4×
“delete possible DNA methylations sites [27].”
InfluentialSelf-citationLin, H.-M., Lee, J.-H., Yadav, H., Kamaraju, A. K., Liu, E., Zhigang, D., Vieira, A., Kim, S.-J., Collins, H., Matschinsky, F., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805379200 · Cited by 189
Pancreatic alpha cell mass in European subjects with type 2 diabetes
Henquin, J. C., & Rahier, J. (2011) · Diabetologia · doi:10.1007/s00125-011-2118-4 · Cited by 185 · cited 1×
“While some researchers have found a decreased b -cell number and increased a -cell number in human T2D compared with non-diabetic islets, others have not found any differences [69–71].”
Thompson, R. F., Fazzari, M. J., Niu, H., Barzilai, N., Simmons, R. A., & Greally, J. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095133 · Cited by 154 · cited 1×
“Importantly, Thompson et al found differential DNA methylation of ,1,400 CpG sites together with altered gene expression in islets of seven week old rats exposed to an intrauterine growth restriction, a model that causes diabetes in elderly rats [78].”
Longitudinal noninvasive PET-based cell mass estimates in a spontaneous diabetes rat model
Souza, F., Simpson, N. R., Raffo, A. J., Saxena, C., Maffei, A., Hardy, M. A., Kilbourn, M. R., Goland, R., Leibel, R. L., Mann, J. J., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27645 · Cited by 152 · cited 2×
“the exocytosis process and apoptosis [28–45].”
Romanov, V. S., Поспелов, В. А., & Pospelova, T. V. (2012) · Biochemistry (Moscow) · doi:10.1134/s000629791206003x · Cited by 143 · cited 2×
“CDKN1A, also known as p21, is a well characterized tumor suppressor and a negative regulator of the cell cycle [67].”
Pinney, S. E., Santos, L. J. J., Han, Y., Stoffers, D. A., & Simmons, R. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2250-1 · Cited by 138 · cited 2×
“Animal studies further support the hypothesis that epigenetic modifications in pancreatic islets may lead to altered gene expression, impaired insulin secretion and subsequently diabetes [15–17].”
Lindgren, C. M., Mahtani, M. M., Widén, E., McCarthy, M. I., Daly, M. J., Kirby, A. W., Reeve, M. P., Kruglyak, L., Parker, A. N., Meyer, J. M., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338629 · Cited by 137 · cited 1×
“Chromosomal and genomic distribution of differentially methylated CpG sites in T2D islets There is an accumulation of genetic variation on certain chromosomes associated with disease [19,20].”
Neurogenin3 inhibits proliferation in endocrine progenitors by inducing Cdkn1a
Miyatsuka, T., Kosaka, Y., Kim, H., & German, M. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004842108 · Cited by 132 · cited 2×
“Cdkn1a (also known as p21) encodes a potent cyclin-dependent kinase inhibitor that regulates cell cycle progression [31] and we therefore tested if overexpression of this gene would affect cell proliferation in clonal b-cells.”
Apoptosis in Cancer - An Update
Sankari, S., Masthan, K. M. K., Babu, N. A., Bhattacharjee, T., & Elumalai, M. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.10.4873 · Cited by 132 · cited 1×
“Finally, based on literature search, genes with known functions in pancreatic islets and/or b-cells [28–40] (Figure 2E), the exocytotic process [41–44] (Figure 2F) and apoptosis [45] (Figure 2G) were found among the genes that showed differential DNA methylation in T2D islets.”
Andersson, S. A., Olsson, A. H., Esguerra, J. L. S., Heimann, E., Ladenvall, C., Edlund, A., Salehi, A., Taneera, J., Degerman, E., Groop, L., et al. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.009 · Cited by 122 · cited 1×
“A deficient exocytosis machinery may result in perturbed insulin secretion [41].”
Self-citationDecreased insulin secretion in type 2 diabetes: a problem of cellular mass or function?
Clark, A., Jones, L. C., de Koning, E. J. P., HANSEN, B. C., & Matthews, D. R. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s169 · Cited by 121 · cited 1×
“While some researchers have found a decreased b-cell number and increased a-cell number in human T2D compared with nondiabetic islets, others have not found any differences [69–71].”
DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets
Hall, E., Dayeh, T., Kirkpatrick, C. L., Wollheim, C. B., Nitert, M. D., & Ling, C. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-76 · Cited by 121 · cited 1×
“While we and others have found epigenetic differences between human b- and a-cells from a modest number of nondiabetic donors [12,13,74,75], to our knowledge there is no available data showing differential DNA methylation in human bcells from patients with T2D compared with non-diabetic donors, nor have any studies an…”
Self-citationMysore, T., Shinkel, T., Collins, J., Salvaris, E., Fisicaro, N., Murray-Segal, L., Johnson, L. E. A., Lepore, D., Walters, S., Stokes, R., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2109 · Cited by 112 · cited 1×
“Finally, based on literature search, genes with known functions in pancreatic islets and/or b -cells [28–40] (Figure 2E), the exocytotic process [41–44] (Figure 2F) and apoptosis [45] (Figure 2G) were found among the genes that showed differential DNA methylation in T2D islets.”
Cyclic AMP Signaling in Pancreatic Islets
Furman, B. L., Ong, W. K., & Pyne, N. J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_13 · Cited by 109 · cited 2×
“Although this is the first study showing that PDE7B affects insulin secretion, other members of this family are known to control cAMP and insulin secretion in b-cells [48].”
BMP4 Regulates Pancreatic Progenitor Cell Expansion through Id2
Hua, H., Zhang, Y.-Q., Dabernat, S., Kritzik, M. R., Dietz, D., Sterling, L., & Sarvetnick, N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600526200 · Cited by 108 · cited 2×
“the exocytosis process and apoptosis [28–45].”
Ruchat, S.-M., Elks, C. E., Loos, R. J. F., Vohl, M., Weisnagel, S. J., Rankinen, T., Bouchard, C., & Përusse, L. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0080-5 · Cited by 108 · cited 2×
“key mechanisms in the pathogenesis of T2D [3–5].”
The signaling hubs at the crossroad of longevity and age-related disease networks
Wolfson, M., Budovsky, A., Tăcutu, R., & Fraifeld, V. E. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.026 · Cited by 104 · cited 1×
“microenvironment in age-related disease [53], it has been shown”
Gene × Environment Interactions in Type 2 Diabetes
Franks, P. W. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0224-9 · Cited by 95
Gardner, C., Robas, N. M., Cawkill, D., & Fidock, M. D. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2743 · Cited by 95 · cited 2×
“PDE7B is a cAMPspecific phosphodiesterase that regulates cellular cAMP levels [47].”
Olsson, A. H., Yang, B. T., Hall, E., Taneera, J., Salehi, A. A., Nitert, M. D., & Ling, C. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0282 · Cited by 94 · cited 3×
“The purity of the islet preparations was determined by expression of endocrine (somatostatin and glucagon) and exocrine (pancreatic lipase, amylase a2A, chymotrypsin 2) markers and dithizone staining [63].”
Self-citationKitaguchi, T., Oya, M., Wada, Y., Tsuboi, T., & Miyawaki, A. (2013) · Biochemical Journal · doi:10.1042/bj20121022 · Cited by 91 · cited 2×
“Finally, based on literature search, genes with known functions in pancreatic islets and/or b -cells [28–40] (Figure 2E), the exocytotic process [41–44] (Figure 2F) and apoptosis [45] (Figure 2G) were found among the genes that showed differential DNA methylation in T2D islets.”
From Endothelial to β Cells: Insights into Pancreatic Islet Microendothelium
Camussi, G., Zanone, M. M., & Favaro, E. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502415 · Cited by 81 · cited 1×
“While EGF is a growth factor important for postnatal expansion of b-cell mass and for the survival of b-cells following stress induced apoptosis [56], VEGFA is responsible for dense islet vascularization and is expressed more in the endocrine than the exocrine part of the pancreas [57].”
Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol
Vikman, J., Jimenez‐Feltström, J., Nyman, P., & Eliasson, L. (2009) · The FASEB Journal · doi:10.1096/fj.08-105734 · Cited by 79 · cited 1×
“Micrographs were analyzed for b-cell content with ImageJ and in-house software programmed in Matlab using methods previously described [14,79].”
Self-citationGene expression profile in obesity and type 2 diabetes mellitus
Das, U. N., & Rao, A. A. (2007) · Lipids in Health and Disease · doi:10.1186/1476-511x-6-35 · Cited by 77
Cai, T., Hirai, H., Zhang, G., Zhang, M., Takahashi, N. K., Kasai, H., Satin, L. S., Leapman, R. D., & Notkins, A. L. (2011) · Diabetologia · doi:10.1007/s00125-011-2221-6 · Cited by 67
Bai, L., Zhang, X., & Ghishan, F. K. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00333.2002 · Cited by 64 · cited 2×
“the exocytosis process and apoptosis [28–45].”
Kirkpatrick, C. L., Marchetti, P., Purrello, F., Piro, S., Bugliani, M., Bosco, D., de Koning, E. J. P., Engelse, M. A., Kerr-Conte, J. A., Pattou, F. N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011053 · Cited by 58 · cited 1×
“Using this method, a cell purity of 8969% (mean 6 SD) was achieved [81].”
Self-citationDietary methyl-consuming compounds and metabolic syndrome
Zhou, S., Zhou, Y., Li, D., & Lun, Y. (2011) · Hypertension Research · doi:10.1038/hr.2011.133 · Cited by 47 · cited 1×
“Another explanation for hypomethylation may be decreased levels of methyl donors [61].”
Zielonka, M., Xia, J., Friedel, R. H., Offermanns, S., & Worzfeld, T. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.05.007 · Cited by 45 · cited 1×
“Additionally, we found altered DNA methylation of members of the Plexin and Semaphorin families, which play a role in axon guidance and are suggested to control glucose homeostasis via regulating communication between pancreatic b-cells [55].”
Wang, H., Gambosova, K., Cooper, Z. A., Holloway, M. P., Kassai, A., Izquierdo, D., Cleveland, K., Boney, C. M., & Altura, R. A. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-66 · Cited by 45
Barbosa, H. C. L., Bordin, S. A., Stoppiglia, L. F., Silva, K., Borelli, M. I., Zotto, H. H. D., Gagliardino, J. J., & Boschero, A. C. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.04.015 · Cited by 42 · cited 2×
“the exocytosis process and apoptosis [28–45].”
Barkefors, I., Fuchs, P. F., Heldin, J., Bergström, T., Forsberg‐Nilsson, K., & Kreuger, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212209 · Cited by 37 · cited 1×
“The protein encoded by EXOC3L2 is part of the exocyst complex [42] and may consequently affect exocytosis of insulin from pancreatic b-cells.”
Exenatide blocks JAK1-STAT1 in pancreatic beta cells
Couto, F. M., Minn, A. H., Pise-Masison, C. A., Radonovich, M., Brady, J. N., Hanson, M. S., Fernandez, L. A., Wang, P., Kendziorski, C. M., & Shalev, A. (2007) · Metabolism · doi:10.1016/j.metabol.2007.02.004 · Cited by 21 · cited 2×
“the exocytosis process and apoptosis [28–45].”
Genetic and Nutritional Factors in the Etiology and Pathogenesis of Diabetes Mellitus1
K�bberling, J., & TILLIL, H. (2015) · World review of nutrition and dietetics · doi:10.1159/000418502 · Cited by 16 · cited 1×
“Family studies together with genome-wide association studies (GWAS) have shown that the genetic background also influences the risk of T2D [2,3].”
Osterhoff, M. A., Möhlig, M., Schwanstecher, M., Seufert, J., Ortmann, J., Schatz, H., & Pfeiffer, A. F. H. (2003) · Cell Calcium · doi:10.1016/s0143-4160(02)00227-0 · Cited by 15 · cited 2×
“the exocytosis process and apoptosis [28–45].”
Isolating Human Islets of Langerhans Causes Loss of Decay Accelerating Factor (CD55) on β-Cells
Tai, J., Sun, H.-T., Liu, W.-H., Melling, C. W. J., Hasilo, C., & White, D. (2008) · Cell Transplantation · doi:10.3727/096368908787648092 · Cited by 3
Research works printed but not linked: 1
- ISNH Sandovici, 2011, Dynamic epigenetic regulation by early-diet and aging of the type 2 diabetes susceptibility gene Hnf4a in pancreatic islets, Proc Natl Acad Sci U S A, 108, 5449
Cited by
Pidsley, R., Zotenko, E., Peters, T. J., Lawrence, M. G., Risbridger, G. P., Molloy, P., Van Djik, S., Muhlhausler, B., Stirzaker, C., & Clark, S. J. (2016) · Genome biology · doi:10.1186/s13059-016-1066-1 · Cited by 1,480
“Widespread aberrations in DNA methylation are a well-established hallmark of many cancers [1] and a growing body of literature shows a role for DNA methylation in the aetiology of other complex human diseases including chronic kidney disease [2], type 2 diabetes [3] and neuropsychiatric disease [4].”
Epigenetics in Human Obesity and Type 2 Diabetes
Ling, C., & Rönn, T. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.009 · Cited by 941
Self-citationJung, M., & Pfeifer, G. P. (2015) · BMC Biology · doi:10.1186/s12915-015-0118-4 · Cited by 535
“lead to perturbed glucagon and insulin secretion [62].”
Lawlor, N., George, J., Bolisetty, M., Kursawe, R., Sun, L., Sivakamasundari, V., Kycia, I., Robson, P., & Stitzel, M. L. (2017) · Genome Research · doi:10.1101/gr.212720.116 · Cited by 562
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01333-7 · Cited by 476
“Besides, the authors identified 1,649 CpG sites and 853 genes in T2D islets with changes in the DNA methylation level, including fat mass and obesity-associated (FTO), potassium voltage-gated channel subfamily Q member 1 (KCNQ1), and transcription factor-7-like-2 (TCF7L2).(148) One study investigated DNA methylation l…”
Metadata
- Authors
- Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., Bacos, K., & Ling, C.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-06
- Volume
- 10
- Issue
- 3
- Pages
- e1004160
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3945174
- OpenAlex
- W2132464305
- Cited by
- 523
- References
- 90
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 37 · 2021: 47 · 2020: 30 · 2019: 41 · 2018: 43 · 2017: 47 · 2016: 50 · 2015: 49 · 2014: 34
- FWCI
- 24.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Lunds Universitet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- DNA methylation, pancreatic islets, type 2 diabetes, insulin secretion, glucagon secretion, pancreatic beta cells, alpha cells, epigenetics, differentially methylated genes, p21, PDE7B, SEPT9, TCF7L2, FTO, KCNQ1, promoter methylation, exocytosis, methylome
- MeSH terms
- Insulin Secretion, Diabetes Mellitus, Type 2, Disease Susceptibility, Exocytosis, Humans, Insulin, Islets of Langerhans, Promoter Regions, Genetic, Genome, Human, CpG Islands, DNA Methylation, Epigenesis, Genetic, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.